Presentation is loading. Please wait.

Presentation is loading. Please wait.

Developmental capacity of in vitro–matured human oocytes retrieved from polycystic ovary syndrome ovaries containing no follicles larger than 6 mm  Luis.

Published byMiles Benson Modified over 6 years ago

Similar presentations

Presentation on theme: "Developmental capacity of in vitro–matured human oocytes retrieved from polycystic ovary syndrome ovaries containing no follicles larger than 6 mm  Luis."— Presentation transcript:

1 Developmental capacity of in vitro–matured human oocytes retrieved from polycystic ovary syndrome ovaries containing no follicles larger than 6 mm  Luis Guzman, M.Sc., Carolina Ortega-Hrepich, M.D., Firas K. Albuz, Ph.D., Greta Verheyen, Ph.D., Paul Devroey, M.D., Ph.D., Johan Smitz, M.D., Ph.D., Michel De Vos, M.D., Ph.D.  Fertility and Sterility  Volume 98, Issue 2, Pages e2 (August 2012) DOI: /j.fertnstert Copyright © 2012 American Society for Reproductive Medicine Terms and Conditions

2 Supplemental Figure 1 Distribution of the cycles according to the embryo transfer. ET = embryo transfer; PCO = polycystic ovaries; PCOS = polycystic ovary syndrome. Fertility and Sterility  , e2DOI: ( /j.fertnstert ) Copyright © 2012 American Society for Reproductive Medicine Terms and Conditions

3 Supplemental Figure 2 (A) Histogram distribution of oocyte diameter before and after in vitro maturation (IVM) culture. (B) Histogram distribution of oocyte diameter according to the maturation status after IVM culture. Fertility and Sterility  , e2DOI: ( /j.fertnstert ) Copyright © 2012 American Society for Reproductive Medicine Terms and Conditions

Download ppt "Developmental capacity of in vitro–matured human oocytes retrieved from polycystic ovary syndrome ovaries containing no follicles larger than 6 mm  Luis."

Similar presentations

Oocyte number as a predictor for ovarian hyperstimulation syndrome and live birth: an analysis of 256,381 in vitro fertilization cycles  Ryan G. Steward,

Oocyte number as a predictor for ovarian hyperstimulation syndrome and live birth: an analysis of 256,381 in vitro fertilization cycles  Ryan G. Steward,
Lisa Marii Cookingham, M. D. , Rachel P. Goossen, B. A. , Amy E. T

Lisa Marii Cookingham, M. D. , Rachel P. Goossen, B. A. , Amy E. T
Supplemented tissue culture medium 199 is a better medium for in vitro maturation of oocytes from women with polycystic ovary syndrome women than human.

Supplemented tissue culture medium 199 is a better medium for in vitro maturation of oocytes from women with polycystic ovary syndrome women than human.
International Committee for Monitoring Assisted Reproductive Technology (ICMART) world report: assisted reproductive technology 2003  Karl G. Nygren,

International Committee for Monitoring Assisted Reproductive Technology (ICMART) world report: assisted reproductive technology 2003  Karl G. Nygren,
Clinically significant and sustained weight loss is achievable in obese women with polycystic ovary syndrome followed in a regular medical practice  Lysanne.

Clinically significant and sustained weight loss is achievable in obese women with polycystic ovary syndrome followed in a regular medical practice  Lysanne.
Demián Glujovsky, M.D., M.Sc., Cynthia Farquhar, M.D., M.P.H. 

Demián Glujovsky, M.D., M.Sc., Cynthia Farquhar, M.D., M.P.H. 
Clinical outcome of non–hCG-primed oocyte in vitro maturation treatment in patients with polycystic ovaries and polycystic ovary syndrome  Michel De Vos,

Clinical outcome of non–hCG-primed oocyte in vitro maturation treatment in patients with polycystic ovaries and polycystic ovary syndrome  Michel De Vos,
Wendy S. Vitek, M. D. , Jeannine Witmyer, Ph. D. , Sandra A. Carson, M

Wendy S. Vitek, M. D. , Jeannine Witmyer, Ph. D. , Sandra A. Carson, M
Yuqian Cui, M. D. , Ph. D. , Yuhua Shi, M. D. , Ph. D. , Linlin Cui, M

Yuqian Cui, M. D. , Ph. D. , Yuhua Shi, M. D. , Ph. D. , Linlin Cui, M
Study of nucleation status in the second cell cycle of human embryo and its impact on implantation rate  Jesus Aguilar, Ph.D., Irene Rubio, Ph.D., Elkin.

Study of nucleation status in the second cell cycle of human embryo and its impact on implantation rate  Jesus Aguilar, Ph.D., Irene Rubio, Ph.D., Elkin.
A giant oocyte in a cohort of retrieved oocytes: does it have any effect on the in vitro fertilization cycle outcome?  Ronit Machtinger, M.D., Joseph.

A giant oocyte in a cohort of retrieved oocytes: does it have any effect on the in vitro fertilization cycle outcome?  Ronit Machtinger, M.D., Joseph.
International Committee for Monitoring Assisted Reproductive Technology: world report on assisted reproductive technology, 2005  Fernando Zegers-Hochschild,

International Committee for Monitoring Assisted Reproductive Technology: world report on assisted reproductive technology, 2005  Fernando Zegers-Hochschild,
Gaps in knowledge among physicians regarding diagnostic criteria and management of polycystic ovary syndrome  Anuja Dokras, M.D., Ph.D., Shailly Saini,

Gaps in knowledge among physicians regarding diagnostic criteria and management of polycystic ovary syndrome  Anuja Dokras, M.D., Ph.D., Shailly Saini,
MRNA expression pattern of insulin-like growth factor components of granulosa cells and cumulus cells in women with and without polycystic ovary syndrome.

MRNA expression pattern of insulin-like growth factor components of granulosa cells and cumulus cells in women with and without polycystic ovary syndrome.
Samuel Santos-Ribeiro, M. D. , Johannie Siffain, M. D. , Nikolaos P

Samuel Santos-Ribeiro, M. D. , Johannie Siffain, M. D. , Nikolaos P
Ovarian size and blood flow in women with polycystic ovary syndrome and their correlations with endocrine parameters  Enrico Carmina, M.D., Francesco.

Ovarian size and blood flow in women with polycystic ovary syndrome and their correlations with endocrine parameters  Enrico Carmina, M.D., Francesco.
Administration of a gonadotropin-releasing hormone antagonist during the 3 days before the initiation of the in vitro fertilization/intracytoplasmic sperm.

Administration of a gonadotropin-releasing hormone antagonist during the 3 days before the initiation of the in vitro fertilization/intracytoplasmic sperm.
Gaps in knowledge among physicians regarding diagnostic criteria and management of polycystic ovary syndrome  Anuja Dokras, M.D., Ph.D., Shailly Saini,

Gaps in knowledge among physicians regarding diagnostic criteria and management of polycystic ovary syndrome  Anuja Dokras, M.D., Ph.D., Shailly Saini,
Zhi-Yong Yang, M.D., Ri-Cheng Chian, Ph.D.  Fertility and Sterility 

Zhi-Yong Yang, M.D., Ri-Cheng Chian, Ph.D.  Fertility and Sterility 
Progression to impaired glucose tolerance or type 2 diabetes mellitus in polycystic ovary syndrome: a controlled follow-up study  Cem Celik, M.D., Nicel.

Progression to impaired glucose tolerance or type 2 diabetes mellitus in polycystic ovary syndrome: a controlled follow-up study  Cem Celik, M.D., Nicel.

Similar presentations

Ads by Google